Recently, the launching ceremony of the 2022 "National Drug Safety Month" and the 7th China Drug Safety Forum, sponsored by the State Food and Drug Administration and undertaken by the Chinese Pharmaceutical Association, People's Daily Online and People's Health, were held in Beijing. Huang Guo, member of the Party Leadership Group and Deputy Director of the State Food and Drug Administration, attended the launching ceremony and delivered a speech. Relevant personnel from the General Administration of Market Supervision, China Association for Science and Technology and other departments, as well as representatives from drug regulatory authorities, news media and science popularization volunteers, attended the launching ceremony. The drug regulatory department undertakes the important responsibility and mission of ensuring people's drug safety and protecting people's life and health. In recent years, it has intensively introduced a series of policies such as the reform of the review and approval system to further release the innovation vitality of the pharmaceutical industry, accelerate the listing of clinically urgently needed and innovative drugs, and better meet the health needs of the people. Huang Guo said that we should further strengthen drug quality supervision, improve people's health and well-being, and promote high-quality development of the pharmaceutical industry. At the same time, he stressed that we should make every effort to ensure the drug safety of the people, adhere to the overall development and safety, strictly prevent and control drug safety risks, improve the quality of the drug regulatory system, strengthen the supervision of key varieties, consolidate the main responsibility of enterprises, and promote the vertical development of special rectification of drug safety. We should continue to deepen the reform of the evaluation and approval system, further release the dividend of reform, stimulate innovation, promote the inheritance and innovative development of traditional Chinese medicine, constantly meet the new needs of the people for drug use, and promote China's transition from a large pharmaceutical country to a powerful pharmaceutical country. We should comprehensively strengthen the construction of drug regulatory capacity, continue to improve the regulatory and standard system, strengthen the technical support system, strengthen intelligent supervision, deepen international cooperation, and improve the scientific, legal, international, and modern level of drug regulation. The theme of this year's "National Drug Safety Month" is "Safe Drug Use with One Heart". At the launching ceremony, the Department of Drug Administration, the Department of Politics and Law, the Department of Drug Registration Relevant leaders of the Department of Science and Technology International Cooperation made keynote speeches around "continuing to strengthen supervision to ensure drug quality and safety and fully protect people's health", "continuing to strengthen the construction of the regulatory system and constantly improve the vaccine regulatory capacity and level", "deepening the reform of the drug review and approval system to promote high-quality development of the pharmaceutical industry", "supporting and promoting the inheritance and innovative development of traditional Chinese medicine", "deepening the promotion of regulatory science and strengthening the construction of regulatory capacity", This paper introduces the practical measures and achievements of the State Food and Drug Administration to strengthen the public's defense line for safe drug use and promote the high-quality development of the industry. The launch ceremony also released the public's top ten drug use tips in 2022. Experts explained the scientific methods of safe drug use around the public concern, popularized the knowledge of safe drug use, improved the public health literacy, and promoted public health. Ensuring drug safety requires the participation of the whole society. As an important brand promotion activity in the field of drug safety in China, the "National Drug Safety Month" activity has been held for 15 consecutive times since 2007 to continuously popularize drug safety knowledge and promote social co governance. The "National Drug Safety Month" in 2022 will be from the middle of November to the middle of December. During the activity, drug regulatory authorities at all levels will organize various forms of publicity activities, carry out drug safety network knowledge competitions, find the best pharmacists around, and promote a series of popular science about drug safety knowledge, so as to increase the public's supervision of drugs